-
IDWeek Live Interview: Dr. Kevin Downes on Practical and Novel Approaches to Therapeutic Drug Monitoring and Antibiotic Dose Optimization
Therapeutic Drug Monitoring (TDM) refers to the practice of tailoring individualized drug dosing regimens for patients by quantitatively assessing drug exposure, pharmacokinetic markers, or pharmacodynamic endpoints based on therapeutic drug…
-
IDWeek Highlights |Dr. Mei Zeng: Racing Against Time! Developing the Predictive Models for Early Identification of Severe Infections in Newborns
Half of all global child deaths under the age of 5 are caused by infections, and half of all sepsis patients worldwide are children, especially newborns. These alarming statistics highlight the significant challenge of infection treatment in pediatric clinical practice. At the recent IDWeek 2023 congress in the United States, a predictive model for severe…
-
IDWeek Highlights |Dr. Yi-min Wang: Bundle Diagnosis for VAP Can Reduce Misdiagnosis and Antibiotic Overuse
Precision treatment starts with accurate diagnosis. The clinical diagnosis of ventilator-associated pneumonia (VAP) is challenging, with a high misdiagnosis rate leading to excessive antibiotic use. At the recent 2023 IDWeek conference in the United States, a clinical trial was reported that utilized a bundled approach to VAP diagnosis and management. The results showed that it…
-
Dr. Chun-hui Li’s Commentary on a Randomized Controlled Trial of Oral Fosfomycin for Down-Step Therapy in ESBL-E Complicated Urinary Tract Infections
Carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) have been designated as “urgent priorities” in antibiotic research and development by the WHO. Besides accelerating the development of new drugs, emphasizing the “repurposing” of existing drugs under antimicrobial stewardship (AMS) can help alleviate the threat of resistant bacteria. At the 2023 IDWeek congress, There is a…
-
IDWeek Highlights | Dr. Jun-yan Qu Comments on a Real-world study of CT vs. CZA in Treating MDR-PA Infections
Editor’s note: Multi-drug resistant organisms (MDRO) are commonly found in bacteria such as Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. In recent years, the emergence and spread of…
-
Prof. Min-Shan Chen: The Key to Liver Cancer Control Lies in the Integration of Medical Concepts and Multidisciplinary Collaboration
Editor’s Note: The 2023 Chinese Congress on Holistic Integrative Oncology (CCHIO), organized by the China Anti-Cancer Association and hosted by Tianjin Medical University Cancer Hospital, will take place in Tianjin…
-
IDWeek Highlights | Dr. Yi Shi Comments on a Single-Center Cohort Study of Colistin Therapy for CRAB Pneumonia
Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is considered one of the most challenging issues among carbapenem-resistant gram-negative bacteria (CRO) due to limited effective treatment options. Colistin, a polymyxin antibiotic used for “repurposing” in the treatment of CRAB, is one of the few choices available in China. A recent presentation at the 2023 IDWeek congress reported findings…
-
Message from Academician Fan Daiming for the 2023 Chinese Congress of Holistic Integrative Oncology
Editor’s Note: Gathering Expertise in China, Uniting Wisdom Across the World. Organized by the China Anti-Cancer Association and hosted by Tianjin Medical University Cancer Institute & Hospital, Tianjin Anti-Cancer Association,…
Connecting Medical Expertise through Media